-
Wegovy, Rybelsus, and Ozempic Eye Side Effects: Semaglutide Linked to NAION
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or "Eye Stroke", Can Cause Vision Loss (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent findings that…
-
Syfovre Safety-Benefit Assessment by Europe’s Drug Regulator Differs From FDA
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment…
-
Wegovy, Rybelsus, and Ozempic Blood Clots Cases Are Not Part of Federal Court MDL at This Time
Semaglutide-related Side Effects Include Ischemic Stroke, Pulmonary Embolism, and Deep Vein Thrombosis (Posted by Tom Lamb at Drug Injury Watch) UPDATE: Cases involving blood clot-related injuries such as deep vein thrombosis or pulmonary embolism with the…
-
Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection (Posted by Tom Lamb at Drug Injury Watch) In the March 2024 edition of the American…
-
Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear (Posted by Tom Lamb at Drug Injury Watch) Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye…
-
Syfovre Case Report: Occlusive Retinal Vasculitis Shortly After Patient’s First Syfovre Injection
Pre-Existing Allergy Toward Polyethylene Glycol (PEG) is Most Recent Causation Theory Offered by Apellis (Posted by Tom Lamb at Drug Injury Watch) In late January 2024, a leading medical journal for ophthalmologists and retina specialists,…